Gennex Laboratories Share Price
15 Sep, 2026 4:01 PM (IST)
Gennex Laboratories Performance
- Today's Low
- ₹10
- Today's High
- ₹11
- 52 Week Low
- ₹7
- 52 Week High
- ₹17
- Open Price₹11
- Previous Close₹11
- Volume713,455
- 50 DMA₹10.90
- 100 DMA₹10.70
- 200 DMA₹11.20
Gennex Laboratories Chart
Investment Returns
- Over 1 Month -6.93%
- Over 3 Month -4.91%
- Over 6 Month + 3.81%
- Over 1 Year -11.2%
Smart Investing Starts Here Start SIP with Gennex Laboratories for Steady Growth!
Gennex Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 10.4
- PEG Ratio
- 0.3
- Market Cap Cr
- 245
- P/B Ratio
- 1.1
- Average True Range
- 0.8
- EPS
- 1
- Dividend Yield
- 0
- MACD Signal
- 0.1
- RSI
- 36.48
- MFI
- 48.45
Latest Stock News Updates
Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication of AGM Notice and eVoting related instructions advertisement published in Business Standard and Saksham (Telugu - Local) on September 09, 2026 for the 41st Annual General Meeting of the Company to be held on September 30, 2026. We request you to take the above information on record and acknowledge receipt of the same.
- BSE India
- 6 days 11 hours ago
We are pleased to inform that our subsidiary company, M/s Deccan Remedies Limited has received approval from the Drugs Control Administration, Government of Andhra Pradesh granting License for Manufacturing of additional Products under form 25 and Test License for the purpose of examination, test or analysis under Form 29. Approval received from DCA, Government of Andhra Pradesh is enclosed herewith for your information and for taking the same on record.
- BSE India
- 1 week ago
With reference to the subject matter, As per the Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby submits 41st Annual Report of Gennex Laboratories Limited for the Financial Year ended March 31, 2026, inter alia, Notice of the Annual General Meeting to be held on Wednesday, September 30, 2026, Director''s Report, Independent Audit Report of Statutory Auditor, Financial Statements (Standalone and Consolidated), being Balance Sheet, Statement of Profit and Loss account & Cash Flow Statement along with the Notes thereto for the Financial Year ended March 31, 2026 have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e., www.gennexlab.com and are also available for inspection at the Registered Office of the Company during office hours. This intimation is also being uploaded on the Company website: www.gennexlab.com.
- BSE India
- 1 week ago
Gennex Laboratories Financials
Gennex Laboratories Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹11.40
- 50 Day
- ₹10.90
- 100 Day
- ₹10.70
- 200 Day
- ₹11.20
Resistance and Support
- R3 12.10
- R2 11.70
- R1 10.90
- S1 9.60
- S2 9.20
- S3 8.40
Gennex Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-09-04 | A.G.M. | |
| 2026-08-14 | Quarterly Results | |
| 2026-05-30 | Audited Results | |
| 2026-04-16 | Others | Inter-alia, to consider 1. Decide regarding the conduct of EGM for Regularization of Additional Director Ms. Khushbu Kachhawa as a Director. 2. Appoint Scrutinizer for EGM. 3. Other business matters. |
| 2026-02-14 | Quarterly Results |
About Gennex Laboratories
Gennex Laboratories is engaged in the business of manufacturing of Bulk Drugs and Intermediaries. View More- NSE Symbol
- GENNEX
- BSE Symbol
- 531739
- ISIN
- INE509C01026
Similar Stocks to Gennex Laboratories
Popular Stocks
Gennex Laboratories FAQs
Gennex Laboratories share price is ₹10 As on 16 September, 2026 | 00:42
The Market Cap of Gennex Laboratories is ₹244.6 Cr As on 16 September, 2026 | 00:42
The P/E ratio of Gennex Laboratories is 10.4 As on 16 September, 2026 | 00:42
The PB ratio of Gennex Laboratories is 1.1 As on 16 September, 2026 | 00:42
The 52 week High & Low of Gennex Laboratories is ₹17.2/₹7 respectively As on 16 September, 2026 | 00:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.